Citigroup’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
VC
PP
PF
NTCM
CI
Citigroup's CLBT Position: Q2 2026 in Review
Citigroup reduced its Cellebrite (CLBT) stake by 4.8% in Q2 2026, selling an estimated $234K and leaving 352,350 shares worth $5.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2120.
Citigroup first reported a position in CLBT in Q4 2021 and has held it in 19 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.
- Citigroup held 352,350 shares of Cellebrite worth $5.14M as of Q2 2026.
- Citigroup sold 17,741 Cellebrite shares in Q2 2026, an estimated $234K.
- Cellebrite made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2120 holding.
- Citigroup first reported a position in Cellebrite in Q4 2021 and has held it in 19 quarters since.
- 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.